These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21698612)

  • 21. Detectable reporter gene expression following transduction of adenovirus and adeno-associated virus serotype 2 vectors within full-thickness osteoarthritic and unaffected canine cartilage in vitro and unaffected guinea pig cartilage in vivo.
    Santangelo KS; Baker SA; Nuovo G; Dyce J; Bartlett JS; Bertone AL
    J Orthop Res; 2010 Feb; 28(2):149-55. PubMed ID: 19658157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breaking the barriers to global gene delivery.
    Weitzman MD; Thistlethwaite PA
    Nat Biotechnol; 2005 Mar; 23(3):305-6. PubMed ID: 15765082
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
    Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A
    Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of viral and nonviral vectors for gene transfer to human endothelial progenitor cells.
    Kealy B; Liew A; McMahon JM; Ritter T; O'Doherty A; Hoare M; Greiser U; Vaughan EE; Maenz M; O'Shea C; Barry F; O'Brien T
    Tissue Eng Part C Methods; 2009 Jun; 15(2):223-31. PubMed ID: 19196124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting adenovirus.
    Wickham TJ
    Gene Ther; 2000 Jan; 7(2):110-4. PubMed ID: 10673715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control.
    Work LM; Ritchie N; Nicklin SA; Reynolds PN; Baker AH
    Gene Ther; 2004 Aug; 11(16):1296-300. PubMed ID: 15292916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway.
    Michael SI; Curiel DT
    Gene Ther; 1994 Jul; 1(4):223-32. PubMed ID: 7584085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precise hit: adeno-associated virus in gene targeting.
    Vasileva A; Jessberger R
    Nat Rev Microbiol; 2005 Nov; 3(11):837-47. PubMed ID: 16261169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted gene-delivery strategies for angiostatic cancer treatment.
    Brandwijk RJ; Griffioen AW; Thijssen VL
    Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral gene therapy strategies: from basic science to clinical application.
    Young LS; Searle PF; Onion D; Mautner V
    J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinctive gene transduction efficiencies of commonly used viral vectors in the retina.
    Zhang SH; Wu JH; Wu XB; Dong XY; Liu XJ; Li CY; Qian-Huang
    Curr Eye Res; 2008 Jan; 33(1):81-90. PubMed ID: 18214745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AAV vectors for hemophilia B gene therapy.
    Chao H; Walsh CE
    Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Viral vectors for the study of gene function analysis].
    Mizuguchi H; Hayakawa T
    Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1653-62. PubMed ID: 12931626
    [No Abstract]   [Full Text] [Related]  

  • 34. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.
    Copreni E; Penzo M; Carrabino S; Conese M
    Gene Ther; 2004 Oct; 11 Suppl 1():S67-75. PubMed ID: 15454960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene delivery to airway epithelial cells in vivo: a direct comparison of apical and basolateral transduction strategies using pseudotyped lentivirus vectors.
    Kremer KL; Dunning KR; Parsons DW; Anson DS
    J Gene Med; 2007 May; 9(5):362-8. PubMed ID: 17380490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AAV vectors for gene correction.
    Cathomen T
    Curr Opin Mol Ther; 2004 Aug; 6(4):360-6. PubMed ID: 15468594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting of adenoviral vectors through a bispecific single-chain antibody.
    Haisma HJ; Grill J; Curiel DT; Hoogeland S; van Beusechem VW; Pinedo HM; Gerritsen WR
    Cancer Gene Ther; 2000 Jun; 7(6):901-4. PubMed ID: 10880021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the heart with gene therapy-optimized gene delivery methods.
    Müller OJ; Katus HA; Bekeredjian R
    Cardiovasc Res; 2007 Feb; 73(3):453-62. PubMed ID: 17097076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and construction of targeted AAVP vectors for mammalian cell transduction.
    Hajitou A; Rangel R; Trepel M; Soghomonyan S; Gelovani JG; Alauddin MM; Pasqualini R; Arap W
    Nat Protoc; 2007; 2(3):523-31. PubMed ID: 17406616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.